©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 115254
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.115254
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.115254
Table 4 Comparative safety outcomes of beta-blockers vs calcium channel blockers
| Outcome | BB (%) | CCB (%) | P value |
| Symptomatic bradycardia | 9.2 | 4.9 | 0.000 |
| Hypotension | 7.2 | 11.5 | 0.000 |
| Syncope | 4.6 | 3.5 | 0.110 |
| Worsening renal function | 6.8 | 8.0 | 0.147 |
| Drug discontinuation | 11.3 | 9.3 | 0.043 |
| Hospitalization due to ADR | 5.1 | 5.6 | 0.623 |
- Citation: Mansoor M, Depar FN, Talha HU, Rashid HU, Ashraf A, Nouman M, Abbas M, Abbasi MT, Sher A. Comparison of beta-blockers vs calcium channel blockers in heart failure with preserved ejection fraction. World J Cardiol 2025; 17(12): 115254
- URL: https://www.wjgnet.com/1949-8462/full/v17/i12/115254.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i12.115254